Product Information
TRIMETHOPRIM 100 MG TABLET is a generic product labeled by Novitium Pharma LLC, priced at $1.3068 per EA under NDC 70954054110. Its NADAC has been published 195 times since Jan 11, 2023.
FDA first approved this application on Oct 28, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Novitium Pharma LLCNDC
70954054110
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TRIMETHOPRIMApproval Type
Generic (ANDA)
FDA Application
ANDA216393FDA Approved
10/28/2022
TE Code
AB
On Market Since
11/4/2022
Pharmacological Classes
Price Statistics
The NADAC for TRIMETHOPRIM 100 MG TABLET has been published 195 times since Jan 11, 2023, and over the history we have for it it has risen 78.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3068 per EA |
|---|---|
| All-time high | $1.7938 (Aug 14, 2024) |
| All-time low | $0.7314 (Jan 11, 2023) |
| 52-week high | $1.6035 |
| 52-week low | $1.1409 |
| Median price | $1.4716 |
| Average price | $1.4210 |
| Largest weekly change | +45.8% (Jan 18, 2023) |
| Weeks tracked | 195 |
| Tracking since | Jan 11, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novitium Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Trimethoprim market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydrofolate Reductase Inhibitor Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIMETHOPRIM 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIMETHOPRIM 100 MG TABLET, manufactured by Novitium Pharma LLC, is $1.3068 per EA (NDC 70954054110), effective Sep 30, 2026.
How has the price of TRIMETHOPRIM 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIMETHOPRIM 100 MG TABLET has risen 78.7%. It has been tracked across 195 weekly CMS publications since Jan 11, 2023.
What are the highest and lowest recorded NADAC prices for TRIMETHOPRIM 100 MG TABLET?
Since Jan 11, 2023, the NADAC for TRIMETHOPRIM 100 MG TABLET has ranged from a low of $0.7314 (Jan 11, 2023) to a high of $1.7938 (Aug 14, 2024), with a median of $1.4716 per EA.
Are there cheaper alternatives to TRIMETHOPRIM 100 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRIMETHOPRIM 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIMETHOPRIM 100 MG TABLET?
TRIMETHOPRIM 100 MG TABLET (NDC 70954054110) is labeled by Novitium Pharma LLC, and CMS classifies it as a generic product.